ADM Tronics Unlimited, Inc. (ADMT)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ADM Tronics Unlimited, Inc. (ADMT) trades at $0.04 with AI Score 45/100 (Grade C). ADM Tronics Unlimited, Inc. develops, manufactures, and sells electronics, chemicals, and engineered products, primarily for medical applications. Market cap: $2.70M, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for ADMT: ADMT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ADMT against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ADMT: the 1 perspectives are evenly split.
How is this calculated? →ADM Tronics Unlimited, Inc. (ADMT) Healthcare & Pipeline Overview
ADM Tronics Unlimited, Inc. develops and manufactures electronics for non-invasive medical applications and specialty chemicals. Operating in the healthcare sector, the company offers devices for diagnostics and therapeutics, alongside chemical products for medical and cosmetic uses, serving markets across the United States, Asia, Australia, and Europe.
What Is the Investment Thesis for ADMT?
ADM Tronics Unlimited, Inc. presents a unique investment proposition within the medical devices and specialty chemicals sectors. The company's diverse product portfolio, spanning electronics, chemicals, and engineering services, offers multiple revenue streams. With a market capitalization of $2.70M and a negative P/E ratio of -900.65, the company's valuation reflects current challenges, indicated by a negative profit margin of -0.2%. However, a gross margin of 38.6% suggests potential for improved profitability. Growth catalysts include expansion of its medical device offerings and increased demand for its specialty chemical products. Key risks include its OTC market listing and limited financial disclosure.
Based on FMP financials and quantitative analysis
ADMT Key Highlights
- Market capitalization of $2.70M indicates a micro-cap company with potential for high growth but also higher risk.
- Negative P/E ratio of -900.65 reflects current unprofitability, requiring further investigation into the underlying causes and potential turnaround strategies.
- Gross margin of 38.6% demonstrates the company's ability to generate revenue above the cost of goods sold, suggesting efficiency in production.
- Beta of 0.23 indicates low volatility compared to the market, which may appeal to risk-averse investors.
- The company operates in the Electronics, Chemical, and Engineering segments, diversifying its revenue streams and reducing dependence on a single product or market.
Who Are ADMT's Competitors?
ADMT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| GBCS Selectis Health, Inc. | $5.21 | +0.00% | $15.98M | 49 |
| DCTH Delcath Systems, Inc. | $13.61 | +3.11% | $469.84M | 73 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.20 | +3.40% | $18.68M | 73 |
| SSII SS Innovations International, Inc. | $3.76 | -0.53% | $752.49M | 72 |
| RSHUF Respiri Limited | $0.06 | +0.00% | $91.52M | 68 |
| EW Edwards Lifesciences Corporation | $95.44 | +1.14% | $54.96B | 58 |
| PETV PetVivo Holdings, Inc. | $0.80 | -4.65% | $24.03M | 58 |
| OWLT Owlet, Inc. | $5.91 | +2.60% | $106.94M | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ADMT's Key Strengths?
- Diverse product portfolio across electronics, chemicals, and engineering.
- Proprietary technology in medical devices and chemical formulations.
- Long-standing experience in the medical and chemical industries.
- Established customer relationships in various markets.
What Are ADMT's Weaknesses?
- Small market capitalization and limited financial resources.
- Negative profitability and low revenue growth.
- Dependence on OTC market listing.
- Limited geographic diversification.
What Could Drive ADMT Stock Higher?
- Potential FDA approval for new medical devices could drive revenue growth.
- Expansion of distribution channels in Asia and Europe may increase market reach.
- Increased demand for specialty chemical products due to environmental regulations.
- Strategic partnerships with healthcare providers could enhance market penetration.
What Are the Key Risks for ADMT?
- Financial-distress signal — its Altman Z-Score of -19.03 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-0.8%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger and more established companies.
- Stringent regulatory requirements and potential product liability claims.
- Economic downturns and fluctuations in demand.
- Technological obsolescence and changing customer preferences.
- Risks associated with OTC market listing, including limited liquidity and disclosure.
What Are the Growth Opportunities for ADMT?
- Expansion of Medical Device Offerings: ADM Tronics can capitalize on the growing demand for non-invasive medical devices by expanding its product portfolio and targeting new therapeutic areas. The global medical device market is projected to reach $600 billion by 2028, offering significant growth potential. By investing in research and development and obtaining regulatory approvals for new devices, ADM Tronics can increase its market share and revenue.
- Increased Demand for Specialty Chemical Products: The company can leverage the increasing demand for water-based primers, adhesives, coatings, and resins in various industries, including healthcare and cosmetics. The global specialty chemicals market is expected to reach $900 billion by 2027, driven by stringent environmental regulations and demand for sustainable solutions. ADM Tronics can focus on developing innovative and environmentally friendly chemical products to capture a larger share of this market.
- Geographic Expansion: ADM Tronics can expand its operations into new geographic markets, particularly in Asia and Europe, where demand for medical devices and specialty chemicals is growing rapidly. By establishing partnerships with local distributors and obtaining necessary regulatory approvals, the company can increase its global presence and revenue streams. This expansion should be strategic and phased, focusing on markets with favorable regulatory environments and growth potential.
- Strategic Acquisitions: ADM Tronics can pursue strategic acquisitions of complementary businesses to expand its product portfolio, market reach, and technological capabilities. By acquiring companies with innovative technologies or established customer bases, ADM Tronics can accelerate its growth and enhance its competitive position. These acquisitions should be carefully evaluated to ensure they align with the company's strategic objectives and financial capabilities.
- Enhanced Research and Development: ADM Tronics can invest in enhanced research and development activities to develop innovative products and technologies that address unmet needs in the medical devices and specialty chemicals markets. By collaborating with universities and research institutions, the company can accelerate its innovation pipeline and gain a competitive edge. This includes focusing on cutting-edge technologies like biocompatible materials and advanced diagnostic tools.
What Opportunities Does ADMT Have?
- Expansion into new therapeutic areas and geographic markets.
- Increased demand for non-invasive medical devices and specialty chemicals.
- Strategic acquisitions of complementary businesses.
- Development of innovative and environmentally friendly products.
What Threats Does ADMT Face?
- Intense competition from larger and more established companies.
- Stringent regulatory requirements and potential product liability claims.
- Economic downturns and fluctuations in demand.
- Technological obsolescence and changing customer preferences.
What Are ADMT's Competitive Advantages?
- Proprietary Technology: ADM Tronics owns proprietary technology in medical electronic therapeutic devices.
- Specialized Chemical Formulations: The company has expertise in developing specialized water-based chemical formulations.
- Regulatory Expertise: ADM Tronics possesses experience in navigating regulatory approval processes for medical devices.
- Long-standing Customer Relationships: The company has established long-term relationships with customers in various industries.
What Does ADMT Do?
ADM Tronics Unlimited, Inc., founded in 1969 and headquartered in Northvale, New Jersey, operates as a developer, manufacturer, and seller of electronics, chemicals, and engineered products. The company's primary focus is on non-invasive medical applications, serving markets in the United States, Australia, Asia, and Europe. ADM Tronics operates through three segments: Electronics, Chemical, and Engineering. The Electronics segment offers proprietary devices used in diagnostics and therapeutics for both humans and animals, as well as electronic controllers for spas and hot tubs. The Chemical segment provides water-based primers, adhesives, coatings, resins, and chemical additives, including anti-static conductive paints and coatings. The Engineering segment focuses on research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies, including medical electronic therapeutic technology. Additionally, the company provides water-based adhesive and related topical formulations for maxillofacial prosthetic medical applications and professional makeup applications for film, TV, and theatrical productions.
What Products and Services Does ADMT Offer?
- Develops and manufactures electronic devices for non-invasive medical applications.
- Produces water-based primers, adhesives, coatings, and resins.
- Offers chemical additives and anti-static conductive paints.
- Provides research, development, and engineering services for medical devices and electronics.
- Creates water-based adhesive formulations for maxillofacial prosthetic medical applications.
- Develops formulations for professional makeup applications in film, TV, and theater.
How Does ADMT Make Money?
- Sales of proprietary electronic devices for medical diagnostics and therapeutics.
- Revenue from the sale of specialty chemical products to various industries.
- Service fees for research, development, and engineering services.
- Licensing of medical electronic therapeutic technology.
What Industry Does ADMT Operate In?
ADM Tronics Unlimited, Inc. operates within the medical devices and specialty chemicals industries. The medical devices industry is characterized by technological innovation, stringent regulatory requirements, and increasing demand for non-invasive diagnostic and therapeutic solutions. The specialty chemicals industry is driven by demand for advanced materials and formulations across various applications, including healthcare and cosmetics. ADM Tronics' competitive landscape includes companies such as BIXT, BZYR, CVSI, DHBUF, and GBCS. The company's ability to navigate regulatory hurdles and develop innovative products will be crucial for success in these competitive markets.
Who Are ADMT's Key Customers?
- Hospitals and clinics using medical diagnostic and therapeutic devices.
- Spas and hot tub manufacturers using electronic controllers.
- Manufacturers using water-based primers, adhesives, and coatings.
- Film, TV, and theatrical productions using makeup formulations.
Company Profile
ADM Tronics Unlimited, Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Northvale, US. The company is led by CEO Andre' DiMino. ADMT has traded publicly since 1990.
ADM Tronics Unlimited, Inc. Financial Trajectory
ADM Tronics Unlimited, Inc. (ADMT) reported $803K in revenue for Q4 2025, a decline of 9.5% compared to the prior quarter. The company recorded a net loss of $115K, with diluted EPS of $-0.00. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, ADMT averaged $-0.00 in diluted EPS.
How ADM Tronics Unlimited, Inc. Is Valued
ADM Tronics Unlimited, Inc. carries a market capitalization of $2.70M, placing it in the micro-cap category. Relative to its peer group, ADMT's quantitative score of 45/100 is below the peer average of 67/100.
ROE -1%Key Financial Metrics
Return on equity for ADM Tronics Unlimited, Inc. stands at -0.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.3%, showing how much profit it generates from its asset base. Its free cash flow yield is 9.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.14 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.1%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
ADM Tronics Unlimited, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -19.03 places it in the distress zone, a signal of elevated financial risk.
ADMT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- ADMT's recent insider buying signals confidence from within, suggesting potential undervaluation.
- The company's focus on innovative medical devices aligns with growing healthcare demands.
- Positive community sentiment indicates a belief in ADMT's long-term growth potential.
- Market perception of ADMT as a disruptive force in niche medical markets could attract further investment.
Bear Case
- Limited market awareness compared to larger players creates uncertainty about ADMT's competitive edge.
- Dependence on specific product lines makes ADMT vulnerable to market shifts or technological advancements.
- Bearish community views highlight concerns about ADMT's profitability and cash flow.
- Recent market volatility may disproportionately impact smaller, less liquid stocks like ADMT.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $803,088 | -$114,856 | -$0.0017 |
| Q3 2025 | $887,498 | -$114,672 | -$0.0017 |
| Q2 2025 | $973,675 | $327,634 | $0.0048 |
| Q1 2025 | $749,719 | -$104,860 | -$0.0016 |
Based on FMP financials and quantitative analysis
ADMT Latest News
No recent news available for ADMT.
ADMT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ADMT.
Price Targets
Wall Street price target analysis for ADMT.
ADMT MoonshotScore
What does this score mean?
The MoonshotScore rates ADMT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andre' DiMino
CEO
Andre' DiMino serves as the CEO of ADM Tronics Unlimited, Inc. His background includes extensive experience in managing and growing technology-focused companies. He has been instrumental in guiding ADM Tronics through various stages of development, focusing on innovation and strategic partnerships. His expertise spans across electronics, chemicals, and engineering, enabling him to effectively lead the company's diverse operations. He oversees a team of 30 employees, driving the company's vision and strategic initiatives.
Track Record: Under Andre' DiMino's leadership, ADM Tronics has focused on expanding its product portfolio and market reach. Key achievements include the development of proprietary medical devices and the establishment of strategic partnerships. He has also overseen the company's efforts to navigate regulatory approvals and maintain compliance. His strategic decisions have been aimed at driving long-term growth and enhancing shareholder value.
ADMT OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that ADM Tronics Unlimited, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and less scrutiny, potentially leading to greater information asymmetry and volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: The lack of readily available financial information increases the difficulty of assessing the company's financial health and performance.
- Lower Liquidity: Reduced trading volumes and wider bid-ask spreads can make it challenging to execute trades efficiently.
- Higher Volatility: OTC stocks are generally more volatile than exchange-listed stocks, increasing the risk of significant price fluctuations.
- Potential for Fraud: The lower regulatory oversight of the OTC market increases the risk of fraudulent activities and scams.
- Limited Investor Protection: Investors in OTC stocks have less protection compared to those in exchange-listed stocks.
- Verify the company's registration and regulatory filings.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Long Operating History: The company has been in operation since 1969, suggesting a degree of stability and experience.
- Diverse Product Portfolio: ADM Tronics offers a range of products and services across different segments.
- Proprietary Technology: The company owns proprietary technology in medical devices and chemical formulations.
- Established Customer Relationships: ADM Tronics has established relationships with customers in various industries.
ADMT Healthcare Stock FAQ
What does ADM Tronics Unlimited, Inc. do?
ADM Tronics Unlimited, Inc. operates as a developer, manufacturer, and seller of electronics, chemicals, and engineered products, primarily for non-invasive medical applications. The company's Electronics segment offers proprietary devices for diagnostics and therapeutics, while the Chemical segment provides water-based primers, adhesives, coatings, and resins. The Engineering segment focuses on research, development, and regulatory services. Additionally, the company provides formulations for maxillofacial prosthetic medical applications and professional makeup applications. This diversified approach allows ADM Tronics to serve multiple markets within the healthcare and cosmetic industries.
What do analysts say about ADMT stock?
As of 2026-03-16, there is no readily available analyst coverage for ADMT stock due to its OTC listing and small market capitalization. Key valuation metrics include a negative P/E ratio of -900.65 and a gross margin of 38.6%. Growth considerations revolve around the company's ability to expand its product portfolio, penetrate new markets, and navigate regulatory hurdles. Investors should conduct thorough due diligence and assess the risks associated with investing in OTC stocks before making any investment decisions. The lack of analyst coverage necessitates independent research and careful evaluation of the company's financial performance and prospects.
What are the main risks for ADMT?
The main risks for ADM Tronics Unlimited, Inc. include intense competition from larger and more established companies in the medical devices and specialty chemicals industries. Stringent regulatory requirements and potential product liability claims pose ongoing challenges. Economic downturns and fluctuations in demand can impact the company's revenue and profitability. Technological obsolescence and changing customer preferences may require continuous innovation and adaptation. Additionally, the company faces risks associated with its OTC market listing, including limited liquidity, disclosure, and investor protection. These factors collectively contribute to the overall risk profile of ADMT.
What are the key factors to evaluate for ADMT?
ADM Tronics Unlimited, Inc. (ADMT) holds an AI score of 45/100 (low). Not financial advice.
How frequently does ADMT data refresh on this page?
ADMT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ADMT's recent stock price performance?
ADM Tronics Unlimited, Inc. (ADMT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio across electronics, chemicals, and engineering. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ADMT overvalued or undervalued right now?
Valuing ADM Tronics Unlimited, Inc. (ADMT) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying ADMT?
Before investing in ADM Tronics Unlimited, Inc. (ADMT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available sources and may be subject to change.
- OTC market data may be limited and less reliable than exchange-listed data.
- AI analysis is pending and may provide additional insights in the future.